Our purpose

We aim to make a difference in patient care through our cutting-edge nanotechnology.

We believe that our rapid, laboratory-quality diagnostic solutions enable physicians to make early, appropriate clinical decisions at the point of need.

Our facilities

Abionic is ISO 13485 certified since 2012. Our abioSCOPE® system and tests meet IVD standards.

Our manufacturing line has been designed to meet the highest international medical standards with a current capacity of 1 million tests produced annually.

Our team

In less than 10 years, we have demonstrated our ability to bring the company to a stage of full expansion. Currently, our team is composed of 50+ highly skilled employees.

Our dynamic team is highly effective, and we are committed to changing the world of in vitro diagnostics (IVD) by bringing rapid diagnostic solutions close to the patient.

Our workplace

We are committed to creating a positive workplace environment and a culture of trust that support dedicated teamwork.

We believe that the success of a company strongly relies on the happiness of its team members.

"At Abionic we can easily see the impact of our work on the company's growth and this is very motivating". Stéphane Broillet, Head of Engineering.

"What I like most here is the working atmosphere, it's very dynamic and it motivates me to do my best, learn and grow quickly". Alison Papaux, R&D Biology Technician.

Meet our management team

(Innovative and entrepreneurial management team )

Nicolas Durand, PhD,
Chief Executive Officer
Iwan Märki, PhD,
Chief Technology Officer
Guillaume Haquette, MSc,
Chief Biology Officer

Meet our board members

(From left to right)

Nicolas Durand, PhD,
CEO
Nader Donzel, MSc and MBA,
Director
Martine Reindle,
Chairman
Iwan Märki, PhD,
CTO
Eric Cornut, PhD,
Director
Barry Wilson, MA,
Director

Our History

Abionic has received numerous awards since it was founded in 2010

2022

IVD CAPSULE PSP IVDR certified

2022

IVD CAPSULE D-DIMER CE marked

2021

Continue expansion of PSP test in key territories

2020

abioSCOPE® commercialisation starts

2019

abioSCOPE® CE marked

2019

Sepsis impact study in the United States

2018

Sepsis impact study in 14 ICUs in 4 EU countries

2018

ISO 13485:2016 certification obtained

2017

Fund-raising of 25 million Swiss francs in series C

2017

First allergy panel test FDA registered

2017

Novel biomarker PSP test for sepsis CE marked

2017

Point-of-care ferritin test CE marked

2016

Ambassador of Health Valley Switzerland

2016

Automated production line ISO certified

2016

New facilities inauguration in Biopôle, Lausanne

2015

First prototype allergy panel ready

2014

Fund-raising of 8.2 million Swiss francs in series B

2012

Swiss Excellence Product Award

2012

Fund-raising of 3.5 million Swiss francs in series A

2012

ISO 13485:2003 certification obtained

2012

First demonstration of the technology

2010

Abionic was founded as a spin-off from the EPFL

Videos

Biology production laboratory 360° tour
Automated capsules assembly line 360° tour